Development of rapid diagnostic kit against sepsis: Barcode-based semi-quantitative measurement of C-reactive protein and lactate
- 21 May 2026
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 279, 117580
Abstract
No abstract availableKeywords
Funding Information
- Dokuz Eylül Üniversitesi (TSA- 2022\u20132923)
- Dokuz Eylül Üniversitesi (6.8.1)
This publication has 26 references indexed in Scilit:
- Sepsis diagnosis and monitoring: Frontiers in innovative technologyClinica Chimica Acta, 2025
- Development of a gold nanoparticle-based lateral flow immunochromatographic assay for the rapid and quantitative detection of thymidine kinase 1 in human serumJournal of Pharmaceutical and Biomedical Analysis, 2024
- Lateral flow assays for detection of disease biomarkersJournal of Pharmaceutical and Biomedical Analysis, 2022
- Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumoniaGenomics, 2021
- A novel silanization agent based single used biosensing system: Detection of C-reactive protein as a potential Alzheimer’s disease blood biomarkerJournal of Pharmaceutical and Biomedical Analysis, 2018
- Biochemical-immunological hybrid biosensor based on two-dimensional chromatography for on-site sepsis diagnosisBiosensors and Bioelectronics, 2017
- Lactate at the crossroads of metabolism, inflammation, and autoimmunityEuropean Journal of Immunology, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Bacterial neonatal sepsis and antibiotic resistance in low-income countriesThe Lancet, 2016
- Emerging Technologies for Next-Generation Point-of-Care TestingTrends in Biotechnology, 2015